134 related articles for article (PubMed ID: 7418712)
1. Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone.
Riva E; Farina PL; Sega R; Tognoni G; Bastain W; McAinsh J
Eur J Clin Pharmacol; 1980 May; 17(5):333-7. PubMed ID: 7418712
[TBL] [Abstract][Full Text] [Related]
2. Bioavailability in man of atenolol and chlorthalidone from a combination formulation.
McAinsh J; Bastain W; Young J; Harry JD
Biopharm Drug Dispos; 1981; 2(2):147-56. PubMed ID: 7248478
[TBL] [Abstract][Full Text] [Related]
3. Bioavailability in man of atenolol and chlorthalidone from a combination formulation.
McAinsh J; Holmes BH; Fitzsimons TJ; Young J
Biopharm Drug Dispos; 1986; 7(3):223-31. PubMed ID: 3730522
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics, pharmacology of atenolol and effect of renal disease.
Wan SH; Koda RT; Maronde RF
Br J Clin Pharmacol; 1979 Jun; 7(6):569-74. PubMed ID: 465278
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive effect of atenolol alone or combined with chlorthalidone in patients with essential hypertension.
Velasco M; Guevara J; Morillo J; RamÃrez A; Urbina-Quintana A; Hernández-Pieretti O
Br J Clin Pharmacol; 1980 May; 9(5):499-504. PubMed ID: 6994790
[No Abstract] [Full Text] [Related]
6. [Treatment of essential arterial hypertension with the fixed-dose combination of atenolol and chlorthalidone (Tenoretic) in a single daily administration].
Lavezzaro GC; Eandi M; Minelli M; Gastaldo D; Noussan P; Angelino PF; Buraglio M
Minerva Cardioangiol; 1982; 30(7-8):359-66. PubMed ID: 7133425
[No Abstract] [Full Text] [Related]
7. Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled study.
Pareek A; Karnik N; Salagre SB; Zawar SD; Joglekar VK; Chandurkar N; Naik GS
Curr Med Res Opin; 2008 Jun; 24(6):1771-9. PubMed ID: 18479589
[TBL] [Abstract][Full Text] [Related]
8. Comparative pharmacokinetic profiles of metoprolol and chlorthalidone administered alone or in combination to healthy volunteers.
Godbillon J; Gerardin A; John VA; Theobald W
Eur J Clin Pharmacol; 1983; 24(5):655-60. PubMed ID: 6873146
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the antihypertensive effect of atenolol in fixed or free combination with chlorthalidone.
Nissinen A; Tuomilehto J
Pharmatherapeutica; 1980; 2(7):462-8. PubMed ID: 7010382
[TBL] [Abstract][Full Text] [Related]
10. Total body and serum potassium during treatment with atenolol in combination with chlorthalidone.
Gotzen R; Hiemstra S
J Int Med Res; 1981; 9(4):292-4. PubMed ID: 7262453
[No Abstract] [Full Text] [Related]
11. [Evaluation of the antihypertensive effectiveness of the atenolol-chlorthalidone combination (Tenoretic)].
Malini PL; Costa FV; Cavallini C; Marata AM; Ambrosioni E; Magnani B
Minerva Cardioangiol; 1982; 30(7-8):375-80. PubMed ID: 7133427
[No Abstract] [Full Text] [Related]
12. Atenolol and chlorthalidone administered alone and in combination for essential hypertension.
Boike SC; Durley Y; Cubberley RB
Clin Pharm; 1982; 1(5):449-53. PubMed ID: 6764166
[No Abstract] [Full Text] [Related]
13. [Use of metoprolol and atenolol, singly or in combination with a diuretic, in the treatment of arterial hypertension].
Centritto V
Boll Soc Ital Cardiol; 1980; 25(5):451-7. PubMed ID: 7284149
[No Abstract] [Full Text] [Related]
14. Atenolol, methyldopa, and chlorthalidone in moderate hypertension.
Webster J; Jeffers TA; Galloway DB; Petrie JC; Barker NP
Br Med J; 1977 Jan; 1(6053):76-8. PubMed ID: 12850
[TBL] [Abstract][Full Text] [Related]
15. Half-strength atenolol-chlorthalidone combination (tenoretic mite) in the treatment of elderly hypertensive patients.
Fogari R; Zoppi A
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):386-93. PubMed ID: 6469428
[TBL] [Abstract][Full Text] [Related]
16. Low-dose atenolol-chlorthalidone combination for treatment of mild hypertension.
Leonetti G; Pasotti C; Capra A
Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):43-7. PubMed ID: 3514487
[TBL] [Abstract][Full Text] [Related]
17. Atenolol and chlorthalidone in combination for hypertension.
Bateman DN; Dean CR; Mucklow JC; Bulpitt CJ; Dollery CT
Br J Clin Pharmacol; 1979 Apr; 7(4):357-63. PubMed ID: 375958
[TBL] [Abstract][Full Text] [Related]
18. Atenolol and chlorthalidone therapy for hypertension: a double-blind comparison.
Curry RC; Schwartz KM; Urban PL
South Med J; 1988 Nov; 81(11):1401-6, 1411. PubMed ID: 3055324
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of atenolol formulations.
Mcainsh J; Simpson WT; Holmes BF; Young J; Ellis SH
Biopharm Drug Dispos; 1980; 1(6):323-32. PubMed ID: 7459427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
